Jane Street
BCTXW

Jane Street’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Jane Street’s Portfolio BCTXW Stock Details BCTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-65,900
Closed -$380K – 9692
2022
Q2 		$380K Buy
+65,900
New +$210K ﹤0.01% 7207

Other funds holding BCTXW

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $706M AUM 48.92% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's BCTXW Position: Q3 2021 in Review

Jane Street sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q3 2021, closing a stake of 10,181 shares — an estimated $18K sold.

Jane Street first reported a position in BCTXW in Q2 2021 and held it in 1 quarter. The position peaked at $18K in Q2 2021. 8 funds tracked by Wall St. Rank hold BCTXW as of Q3 2021.

  • Jane Street reported no remaining BriaCell Therapeutics Corp Warrant position as of Q3 2021 after selling out during the quarter.
  • Jane Street sold 10,181 BriaCell Therapeutics Corp Warrant shares in Q3 2021, an estimated $18K.
  • Jane Street first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2021 and held it in 1 quarter.
  • Jane Street's BriaCell Therapeutics Corp Warrant position peaked at $18K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.